osteoporosis

(redirected from Glucocorticoid-induced osteoporosis)
Also found in: Thesaurus, Medical, Encyclopedia.

os·te·o·po·ro·sis

 (ŏs′tē-ō-pə-rō′sĭs)
n. pl. os·te·o·po·ro·ses (-sēz)
A disease characterized by a decrease in bone mass and density, occurring especially in postmenopausal women, resulting in a predisposition to fractures.

[New Latin : osteo- + Greek poros, passage, pore; see pore2 + -osis.]

os′te·o·po·rot′ic (-rŏt′ĭk) adj.

osteoporosis

(ˌɒstɪəʊpɔːˈrəʊsɪs)
n
(Pathology) porosity and brittleness of the bones due to loss of calcium from the bone matrix
[C19: from osteo- + pore2 + -osis]
ˌosteopoˈrotic adj

os•te•o•po•ro•sis

(ˌɒs ti oʊ pəˈroʊ sɪs)

n.
a disorder in which the bones become increasingly porous, brittle, and subject to fracture, owing to loss of calcium and other mineral components.
[1840–50; osteo- + Greek pór(os) passage, pore2 + -osis]
os`te•o•po•rot′ic (-ˈrɒt ɪk) adj.

os·te·o·po·ro·sis

(ŏs′tē-ō-pə-rō′sĭs)
A condition in which the bones become porous and weak from loss of minerals, especially calcium.

osteoporosis

the rarefaction of bone, resulting in abnormally porous and weak bony tissue.
See also: Body, Human, Bones

osteoporosis

A group of diseases in which the resorption of bone outpaces the deposit of bone. Bones become lighter and more porous, making them susceptible to fracture.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.osteoporosis - abnormal loss of bony tissue resulting in fragile porous bones attributable to a lack of calcium; most common in postmenopausal women
pathology - any deviation from a healthy or normal condition
dowager's hump - abnormal spinal curvature that results when osteoporosis causes the spine to collapse; seen most often in elderly women
Translations
osteoporóza
luukatoosteoporoosi
csontritkulás

osteoporosis

[ˌɒstɪəʊpɔːˈrəʊsɪs] Nosteoporosis f inv

osteoporosis

[ˌɒstiəʊpəˈrəʊsɪs] nostéoporose f

os·te·o·po·ro·sis

n. osteoporosis, pérdida en la densidad del hueso.

osteoporosis

n osteoporosis f
References in periodicals archive ?
Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.
There are different types of mechanisms of glucocorticoid-induced osteoporosis; glucocorticoids prevent vitamin D to form the active metabolite 1.25- dihydroxy vitamin D.
M2 EQUITYBITES-June 11, 2018-Amgen awarded EC approval for third indication for Prolia to treat glucocorticoid-induced osteoporosis
Global Banking News-June 11, 2018-Amgen awarded EC approval for third indication for Prolia to treat glucocorticoid-induced osteoporosis
M2 PHARMA-June 11, 2018-Amgen awarded EC approval for third indication for Prolia to treat glucocorticoid-induced osteoporosis
Medical researchers from North America, Brazil, and Europe discuss the physiology of the calcium-parathyroid hormone-vitamin D axis; the assays of vitamin D and its binding protein; practical issues in vitamin D replacement; its extra-skeletal effects; hypercalcemic states associated with abnormalities of vitamin D metabolism; vitamin D in children and their nutritional requirements for it; and vitamin D and hypoparathyroidism, primary hyperparathyroidism, secondary hyperparathyroid states, glucocorticoid-induced osteoporosis, sarcopenia and other age-related diseases, diabetes, and diseases in pediatrics.
Our results showed that the ZGW significantly increased the expression levels of Wnt1, low-density lipoprotein receptor-related protein 5, and beta-catenin proteins in osteoblasts and BMSCs of glucocorticoid-induced osteoporosis rats after eight weeks of administration [132].
Weinstein, "Glucocorticoid-induced osteoporosis and osteonecrosis," Endocrinology and Metabolism Clinics of North America, vol.
Additionally, data will be presented from the Phase 3 study in patients with glucocorticoid-induced osteoporosis (GiOP), as well as data demonstrating that treatment with Prolia prevents deterioration in the trabecular microstructure at the distal tibia.
Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord.
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int.
The research team led by Professor Lyu and Professor Zhang further found that the aberrant elevated "CKIP-1" expression in osteoblasts could inhibit bone formation and contribute to the reduction in bone formation during ageing as well as in the development of glucocorticoid-induced osteoporosis. Nevertheless, the function of "CKIP-1" on the process of bone formation reduction caused by microgravity in space is still not yet known.

Full browser ?